Report Scope & Overview:
Onychomycosis Market Size was valued at USD 3.40 Billion in 2023 to USD 4.90 Billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.29% during the forecast period (2023 - 2030)
Executive Summary:
The global Onychomycosis market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.
Market Segmentations:
Global Onychomycosis Market: By Company
Abbott Laboratories
Glaxosmithkline
Pfizer
Bausch Health
Galderma
Janssen Biotech
Bristol Meyer Squibb
Topica Pharmaceuticals
Sanofi
Novartis
The global Onychomycosis market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.
Market Size and Growth: The market size for onychomycosis treatments is significant due to the widespread prevalence of the condition globally. Estimates suggest that millions of people are affected by onychomycosis, contributing to a substantial market size for antifungal medications, topical treatments, and medical devices. The market continues to grow as new treatment modalities and innovations emerge.
Key Factors Driving the Market:
- Prevalence of Onychomycosis: The high prevalence of onychomycosis, particularly among older adults and individuals with certain risk factors such as diabetes, compromised immunity, or nail trauma, drives demand for effective treatments.
- Increasing Awareness and Diagnosis: Greater awareness among patients and healthcare providers about the signs, symptoms, and consequences of onychomycosis leads to early diagnosis and treatment initiation, boosting market demand.
- Technological Advancements: Advances in antifungal medications, topical treatments, and medical devices for onychomycosis management contribute to market growth by offering improved efficacy, safety, and patient convenience.
- Patient Preference for Non-invasive Treatments: The preference for non-invasive or minimally invasive treatment options, such as topical antifungals and laser therapy, drives market demand for alternatives to systemic medications or surgical interventions.
- Aging Population: The aging population, particularly in developed regions, represents a significant market demographic for onychomycosis treatments, as older adults are more susceptible to fungal infections due to age-related changes in nail structure and immune function.
Trends:
- Topical Antifungal Innovations: The development of novel topical antifungal formulations, including nail lacquers, gels, and solutions, with improved penetration and efficacy against fungal pathogens is a growing trend in the onychomycosis market.
- Laser Therapy: The adoption of laser therapy for onychomycosis treatment, either as monotherapy or in combination with other modalities, is gaining popularity due to its potential for targeted fungal eradication and minimal side effects.
- Patient Education and Self-care: Patient education initiatives and OTC products for at-home management of onychomycosis, such as antifungal creams, ointments, and nail care kits, are trending as individuals seek convenience and control over their treatment.
- Combination Therapies: The exploration of combination therapies combining antifungal medications with adjunctive treatments, such as physical debridement, nail avulsion, or photodynamic therapy, is a trend aimed at enhancing treatment efficacy and reducing recurrence rates.
Challenges:
- Treatment Resistance: The emergence of antifungal resistance poses a challenge in the management of onychomycosis, highlighting the need for alternative treatment strategies and ongoing surveillance for drug-resistant strains.
- Relapse and Recurrence: Onychomycosis is prone to relapse and recurrence, even after successful treatment, necessitating long-term maintenance therapy and preventive measures to minimize the risk of reinfection.
- Patient Compliance: Poor patient compliance with treatment regimens, particularly for topical medications or lengthy systemic therapies, can affect treatment outcomes and contribute to treatment failure or recurrence.
- Limited Insurance Coverage: Limited insurance coverage for onychomycosis treatments, especially cosmetic or elective procedures, may pose financial barriers to access for some patients, impacting market demand for certain interventions.
Market Segmentations:
Global Onychomycosis Market: By Company
Abbott Laboratories
Glaxosmithkline
Pfizer
Bausch Health
Galderma
Janssen Biotech
Bristol Meyer Squibb
Topica Pharmaceuticals
Sanofi
Novartis
Global Onychomycosis Market: By Type
Distal Subungual Onychomycosis
White Superficial Onychomycosis
Proximal Subungual Onychomycosis
Candida Onychomycosis
Others
Global Onychomycosis Market: By Application
Hospital Pharmacies
Retail Pharmacies
Others
Global Onychomycosis Market: Regional Analysis
The regional analysis of the global Onychomycosis market provides insights into the market's performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Onychomycosis market report are as follows:
North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Onychomycosis in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.
Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Onychomycosis in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.
Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Onychomycosis in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.
Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.
South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Onychomycosis in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 3.40 Billion |
| Market Size 2030 | USD 4.90 Billion |
| Compound Annual Growth Rate (CAGR) | 16.61% ( 2023-2030) |
| Base Year | 2022 |
| Forecast Period | 2024-2033 |
| Historical Data | 2019-2023 |
| Forecast Units | Value ( USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | Distal Subungual Onychomycosis White Superficial Onychomycosis Proximal Subungual Onychomycosis Candida Onychomycosis Others |
| By Application | Hospital Pharmacies Retail Pharmacies |
| Key Companies Profiled | Abbott Laboratories Glaxosmithkline Pfizer Bausch Health Galderma Janssen Biotech Bristol Meyer Squibb Topica Pharmaceuticals Sanofi Novartis |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase Onychomycosis Market Report:
Firstly, Onychomycosis market report provides invaluable insights into market dynamics, encompassing factors like industry trends, consumer behavior, and competitive analysis. By understanding these dynamics, businesses can identify opportunities for growth and anticipate potential threats, empowering them to make informed decisions that align with their strategic objectives.
Secondly, the quality and reliability of market research reports are paramount. Trusted sources and rigorous methodologies ensure the accuracy and credibility of the data presented. This reliability instills confidence in businesses, enabling them to base their strategies on solid foundations and navigate uncertainties with greater certainty.
Thirdly, Onychomycosis market research reports offer a cost-effective solution for accessing comprehensive market intelligence. Rather than investing time and resources in conducting extensive research internally, businesses can rely on these reports to deliver actionable insights in a fraction of the time. This efficiency translates into cost savings and allows organizations to allocate resources more strategically.
Moreover, Onychomycosis market research reports provide deep insights into consumer behavior, helping businesses understand preferences, trends, and purchasing patterns. By leveraging this information, companies can tailor their products and services to meet evolving customer needs, fostering customer satisfaction and loyalty.
Lastly, Onychomycosis market research reports aid in strategic planning by facilitating informed decision-making. From identifying growth opportunities to mitigating risks, these reports equip businesses with the knowledge needed to develop effective strategies that drive sustainable growth and maintain a competitive edge in the market.
Objectives of Onychomycosis Market Study:
Understanding Market Dynamics: Onychomycosis Market research reports aim to provide a comprehensive understanding of the market environment, including industry trends, consumer behavior, and competitive landscape. By analyzing market dynamics, businesses can make informed decisions and adapt their strategies to meet evolving market demands.
Identifying Growth Opportunities: Another objective of Onychomycosis market research reports is to identify potential growth opportunities within the market. By analyzing market trends and consumer preferences, businesses can pinpoint areas of unmet needs or underserved segments, allowing them to develop targeted strategies to capitalize on these opportunities.
Assessing Competitor Strategies: Onychomycosis Market reports also help businesses assess competitor strategies and market positioning. By analyzing competitor performance, product offerings, and marketing tactics, companies can identify competitive strengths and weaknesses, enabling them to refine their own strategies and gain a competitive advantage.
Mitigating Risks: Understanding market risks is another key objective of Onychomycosis market reports. By conducting thorough market analysis, businesses can identify potential threats such as changing consumer preferences, regulatory changes, or new market entrants. This allows them to develop risk mitigation strategies to safeguard their business operations.
Informing Decision Making: Ultimately, the primary objective of Onychomycosis market reports is to provide actionable insights that inform strategic decision-making. By providing data-driven insights and recommendations, market research reports empower businesses to make informed decisions regarding product development, marketing strategies, and resource allocation, ultimately driving business growth and profitability.
Frequently Asked Questions
Onychomycosis Market Size was valued at USD 3.40 Billion in 2023 to USD 4.90 Billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.29% during the forecast period (2023 - 2030)
Factors driving growth include increasing prevalence of onychomycosis, rising awareness about the condition, advancements in treatment options, and growing demand for effective and convenient therapies.
Challenges include low treatment efficacy rates, potential side effects of oral antifungal drugs, long treatment durations, high recurrence rates, and difficulties in reaching the site of infection.
The market is expected to witness steady growth due to increasing awareness, advancements in treatment options such as novel topical formulations and combination therapies, and ongoing research into more effective and targeted antifungal treatments. Additionally, technological innovations in diagnostic methods and telemedicine platforms may improve access to care and enhance patient outcomes.
TABLE OF CONTENT
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Onychomycosis Market Size Growth Rate by Type:
1.2.2 Distal Subungual Onychomycosis
1.2.3 White Superficial Onychomycosis
1.2.4 Proximal Subungual Onychomycosis
1.2.5 Candida Onychomycosis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Onychomycosis Market Growth by Application:
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Onychomycosis Market Perspective
2.2 Onychomycosis Growth Trends by Region
2.2.1 Global Onychomycosis Market Size by Region:
2.2.2 Onychomycosis Historic Market Size by Region
2.2.3 Onychomycosis Forecasted Market Size by Region
2.3 Onychomycosis Market Dynamics
2.3.1 Onychomycosis Industry Trends
2.3.2 Onychomycosis Market Drivers
2.3.3 Onychomycosis Market Challenges
2.3.4 Onychomycosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Onychomycosis Players by Revenue
3.1.1 Global Top Onychomycosis Players by Revenue
3.1.2 Global Onychomycosis Revenue Market Share by Players
3.2 Global Onychomycosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Onychomycosis Revenue
3.4 Global Onychomycosis Market Concentration Ratio
3.4.1 Global Onychomycosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Onychomycosis Revenue in 2023
3.5 Onychomycosis Key Players Head office and Area Served
3.6 Key Players Onychomycosis Product Solution and Service
3.7 Date of Enter into Onychomycosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Onychomycosis Breakdown Data by Type
4.1 Global Onychomycosis Historic Market Size by Type
4.2 Global Onychomycosis Forecasted Market Size by Type
5 Onychomycosis Breakdown Data by Application
5.1 Global Onychomycosis Historic Market Size by Application
5.2 Global Onychomycosis Forecasted Market Size by Application
6 North America
6.1 North America Onychomycosis Market Size
6.2 North America Onychomycosis Market Growth Rate by Country:
6.3 North America Onychomycosis Market Size by Country
6.4 North America Onychomycosis Market Size by Country
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Onychomycosis Market Size
7.2 Europe Onychomycosis Market Growth Rate by Country:
7.3 Europe Onychomycosis Market Size by Country
7.4 Europe Onychomycosis Market Size by Country
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Onychomycosis Market Size
8.2 Asia-Pacific Onychomycosis Market Growth Rate by Region:
8.3 Asia-Pacific Onychomycosis Market Size by Region
8.4 Asia-Pacific Onychomycosis Market Size by Region
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Onychomycosis Market Size
9.2 Latin America Onychomycosis Market Growth Rate by Country:
9.3 Latin America Onychomycosis Market Size by Country
9.4 Latin America Onychomycosis Market Size by Country
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Onychomycosis Market Size
10.2 Middle East & Africa Onychomycosis Market Growth Rate by Country:
10.3 Middle East & Africa Onychomycosis Market Size by Country
10.4 Middle East & Africa Onychomycosis Market Size by Country
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Onychomycosis Introduction
11.1.4 Abbott Laboratories Revenue in Onychomycosis Business
11.1.5 Abbott Laboratories Recent Development
11.2 Glaxosmithkline
11.2.1 Glaxosmithkline Company Detail
11.2.2 Glaxosmithkline Business Overview
11.2.3 Glaxosmithkline Onychomycosis Introduction
11.2.4 Glaxosmithkline Revenue in Onychomycosis Business
11.2.5 Glaxosmithkline Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Onychomycosis Introduction
11.3.4 Pfizer Revenue in Onychomycosis Business
11.3.5 Pfizer Recent Development
11.4 Bausch Health
11.4.1 Bausch Health Company Detail
11.4.2 Bausch Health Business Overview
11.4.3 Bausch Health Onychomycosis Introduction
11.4.4 Bausch Health Revenue in Onychomycosis Business
11.4.5 Bausch Health Recent Development
11.5 Galderma
11.5.1 Galderma Company Detail
11.5.2 Galderma Business Overview
11.5.3 Galderma Onychomycosis Introduction
11.5.4 Galderma Revenue in Onychomycosis Business
11.5.5 Galderma Recent Development
11.6 Janssen Biotech
11.6.1 Janssen Biotech Company Detail
11.6.2 Janssen Biotech Business Overview
11.6.3 Janssen Biotech Onychomycosis Introduction
11.6.4 Janssen Biotech Revenue in Onychomycosis Business
11.6.5 Janssen Biotech Recent Development
11.7 Bristol Meyer Squibb
11.7.1 Bristol Meyer Squibb Company Detail
11.7.2 Bristol Meyer Squibb Business Overview
11.7.3 Bristol Meyer Squibb Onychomycosis Introduction
11.7.4 Bristol Meyer Squibb Revenue in Onychomycosis Business
11.7.5 Bristol Meyer Squibb Recent Development
11.8 Topica Pharmaceuticals
11.8.1 Topica Pharmaceuticals Company Detail
11.8.2 Topica Pharmaceuticals Business Overview
11.8.3 Topica Pharmaceuticals Onychomycosis Introduction
11.8.4 Topica Pharmaceuticals Revenue in Onychomycosis Business
11.8.5 Topica Pharmaceuticals Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Onychomycosis Introduction
11.9.4 Sanofi Revenue in Onychomycosis Business
11.9.5 Sanofi Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Onychomycosis Introduction
11.10.4 Novartis Revenue in Onychomycosis Business
11.10.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Onychomycosis Market Size Growth Rate by Type:
1.2.2 Distal Subungual Onychomycosis
1.2.3 White Superficial Onychomycosis
1.2.4 Proximal Subungual Onychomycosis
1.2.5 Candida Onychomycosis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Onychomycosis Market Growth by Application:
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Onychomycosis Market Perspective
2.2 Onychomycosis Growth Trends by Region
2.2.1 Global Onychomycosis Market Size by Region:
2.2.2 Onychomycosis Historic Market Size by Region
2.2.3 Onychomycosis Forecasted Market Size by Region
2.3 Onychomycosis Market Dynamics
2.3.1 Onychomycosis Industry Trends
2.3.2 Onychomycosis Market Drivers
2.3.3 Onychomycosis Market Challenges
2.3.4 Onychomycosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Onychomycosis Players by Revenue
3.1.1 Global Top Onychomycosis Players by Revenue
3.1.2 Global Onychomycosis Revenue Market Share by Players
3.2 Global Onychomycosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Onychomycosis Revenue
3.4 Global Onychomycosis Market Concentration Ratio
3.4.1 Global Onychomycosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Onychomycosis Revenue in 2023
3.5 Onychomycosis Key Players Head office and Area Served
3.6 Key Players Onychomycosis Product Solution and Service
3.7 Date of Enter into Onychomycosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Onychomycosis Breakdown Data by Type
4.1 Global Onychomycosis Historic Market Size by Type
4.2 Global Onychomycosis Forecasted Market Size by Type
5 Onychomycosis Breakdown Data by Application
5.1 Global Onychomycosis Historic Market Size by Application
5.2 Global Onychomycosis Forecasted Market Size by Application
6 North America
6.1 North America Onychomycosis Market Size
6.2 North America Onychomycosis Market Growth Rate by Country:
6.3 North America Onychomycosis Market Size by Country
6.4 North America Onychomycosis Market Size by Country
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Onychomycosis Market Size
7.2 Europe Onychomycosis Market Growth Rate by Country:
7.3 Europe Onychomycosis Market Size by Country
7.4 Europe Onychomycosis Market Size by Country
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Onychomycosis Market Size
8.2 Asia-Pacific Onychomycosis Market Growth Rate by Region:
8.3 Asia-Pacific Onychomycosis Market Size by Region
8.4 Asia-Pacific Onychomycosis Market Size by Region
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Onychomycosis Market Size
9.2 Latin America Onychomycosis Market Growth Rate by Country:
9.3 Latin America Onychomycosis Market Size by Country
9.4 Latin America Onychomycosis Market Size by Country
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Onychomycosis Market Size
10.2 Middle East & Africa Onychomycosis Market Growth Rate by Country:
10.3 Middle East & Africa Onychomycosis Market Size by Country
10.4 Middle East & Africa Onychomycosis Market Size by Country
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Onychomycosis Introduction
11.1.4 Abbott Laboratories Revenue in Onychomycosis Business
11.1.5 Abbott Laboratories Recent Development
11.2 Glaxosmithkline
11.2.1 Glaxosmithkline Company Detail
11.2.2 Glaxosmithkline Business Overview
11.2.3 Glaxosmithkline Onychomycosis Introduction
11.2.4 Glaxosmithkline Revenue in Onychomycosis Business
11.2.5 Glaxosmithkline Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Onychomycosis Introduction
11.3.4 Pfizer Revenue in Onychomycosis Business
11.3.5 Pfizer Recent Development
11.4 Bausch Health
11.4.1 Bausch Health Company Detail
11.4.2 Bausch Health Business Overview
11.4.3 Bausch Health Onychomycosis Introduction
11.4.4 Bausch Health Revenue in Onychomycosis Business
11.4.5 Bausch Health Recent Development
11.5 Galderma
11.5.1 Galderma Company Detail
11.5.2 Galderma Business Overview
11.5.3 Galderma Onychomycosis Introduction
11.5.4 Galderma Revenue in Onychomycosis Business
11.5.5 Galderma Recent Development
11.6 Janssen Biotech
11.6.1 Janssen Biotech Company Detail
11.6.2 Janssen Biotech Business Overview
11.6.3 Janssen Biotech Onychomycosis Introduction
11.6.4 Janssen Biotech Revenue in Onychomycosis Business
11.6.5 Janssen Biotech Recent Development
11.7 Bristol Meyer Squibb
11.7.1 Bristol Meyer Squibb Company Detail
11.7.2 Bristol Meyer Squibb Business Overview
11.7.3 Bristol Meyer Squibb Onychomycosis Introduction
11.7.4 Bristol Meyer Squibb Revenue in Onychomycosis Business
11.7.5 Bristol Meyer Squibb Recent Development
11.8 Topica Pharmaceuticals
11.8.1 Topica Pharmaceuticals Company Detail
11.8.2 Topica Pharmaceuticals Business Overview
11.8.3 Topica Pharmaceuticals Onychomycosis Introduction
11.8.4 Topica Pharmaceuticals Revenue in Onychomycosis Business
11.8.5 Topica Pharmaceuticals Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Onychomycosis Introduction
11.9.4 Sanofi Revenue in Onychomycosis Business
11.9.5 Sanofi Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Onychomycosis Introduction
11.10.4 Novartis Revenue in Onychomycosis Business
11.10.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
Glaxosmithkline
Pfizer
Bausch Health
Galderma
Janssen Biotech
Bristol Meyer Squibb
Topica Pharmaceuticals
Sanofi
Novartis
Glaxosmithkline
Pfizer
Bausch Health
Galderma
Janssen Biotech
Bristol Meyer Squibb
Topica Pharmaceuticals
Sanofi
Novartis
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast